Amgen Inc. Common Stock (AMG)
XDUS
Delayed Data
Oct 19, 2026, 06:00 AM
Day's Range
380.5552 wk Range
247.85Overview - AMG - Amgen Inc. Common Stock
Key Statistics
Valuation
Enterprise Value
45.47B
P/E (Trailing)
‪26.91‬
PEG Ratio
‪0.41‬
Price / Book
‪17.82‬
EV / EBITDA
‪2.69‬
Profitability
Gross Margin
‪72.04%‬
Profit Margin
‪67.24%‬
Operating Margin
‪31.92%‬
Return on Assets
‪8.51%‬
Return on Equity
‪89.06%‬
Ownership
Shares Outstanding
540.60M
Price stats
50-Day Avg
‪360.09‬
200-Day Avg
‪318.03‬
Dividends
Frequency
Quarterly
Peers - AMG - Amgen Inc. Common Stock
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- AMGXDUSAmgen Inc.+32.95%52-week change26.92P/E (Trailing)‪67.24%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+43.34%52-week change17.66P/E (Trailing)‪74.80%‬Profit Margin
- IDPXDUSBiogen Inc.+40.40%52-week change23.81P/E (Trailing)‪75.69%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+38.89%52-week change-11.74P/E (Trailing)‪58.75%‬Profit Margin
- BAYNXDUSBayer AG+38.13%52-week change-12.00P/E (Trailing)‪58.75%‬Profit Margin
- 7XPXDUSOrganon & Co.+31.68%52-week change17.05P/E (Trailing)‪53.29%‬Profit Margin
- BRMXDUSBristol-Myers Squibb Company+31.19%52-week change16.07P/E (Trailing)‪71.08%‬Profit Margin
Profile Summary - AMG - Amgen Inc. Common Stock
About
Amgen Inc. is a global biotechnology company that discovers, develops, manufactures, and commercializes human therapeutics. Its current portfolio focuses on serious diseases across oncology, cardiovascular disease, inflammation, bone health, nephrology, and rare diseases, with medicines delivered through biologics…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
